[1]
|
Reddy, D., Njala, J., Stocker, P., Schooley, A., Flores, M., Tseng, C.H., et al. (2015) High-Risk Human Papilloma-Virus in HIV-Infected Women Undergoing Cervical Cancer Screening in Lilongwe, Malawi: A Pilot Study. International Journal of STD & AIDS, 26, 379-387. https://doi.org/10.1177/0956462414539149
|
[2]
|
Kashyap, N., Krishnan, N., Kaur, S. and Ghai, S. (2019) Risk Factors of Cervical Cancer. Asia-Pacific Journal of Oncology Nursing, 6, 308-314.
https://doi.org/10.4103/apjon.apjon_73_18
|
[3]
|
Castellsagué, X. (2008) Natural History and Epidemiology of HPV Infection and Cervical Cancer. Gynecologic Oncology, 110, S4-S7.
https://doi.org/10.1016/j.ygyno.2008.07.045
|
[4]
|
Bosch, F.X. and De Sanjosé, S. (2007) The Epidemiology of Human Papillomavirus Infection and Cervical Cancer. Disease Markers, 23, 213-227.
https://doi.org/10.1155/2007/914823
|
[5]
|
Munoz, N., Bosch, F.X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K.V., et al. (2003) Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. The New England Journal of Medicine, 348, 518-527.
https://doi.org/10.1056/NEJMoa021641
|
[6]
|
GLOBOCAN (2020) Incidence du Cancer au Burkina Faso. Global Cancer Observatory, 927.
|
[7]
|
Zohoncon, T.M., Ouedraogo, R.A., Djigma, F.W., Traore, L., Ouedraogo, T.W.C., Ilboudo, M., et al. (2022) Molecular Epidemiology of High-Risk Human Papillomavirus Infection in Burkina Faso. In: Budak, M. and Rajkumar, R., Eds., Molecular Mechanisms in Cancer, IntechOpen, London.
|
[8]
|
Kagoné, T.S., Paré, P.G., Dembélé, A., Kania, D., Zida, S., Thiéba, B.B., et al. (2022) Cervical Cancer in the Hauts-Bassins Region of Burkina Faso: Results of a Screening Campaign by Visual Inspection with Acetic Acid (VIA Screening in Burkina Faso). African Journal of Reproductive Health, 26, 97-103.
|
[9]
|
Ouedraogo, R.A., Zohoncon, T.M., Ouattara, A.K. and Simpore, J. (2020) Prédominance du papillomavirus humain 56 dans une sous-population de femmes sexuellement actives à Garango, Centre-Est, Burkina Faso. Journal of Applied Biosciences, 150, 15499-15509. https://doi.org/10.35759/JABs.150.10
|
[10]
|
Traore, I.M.A., Zohoncon, T.M., Dembele, A., Djigma, F.W., Obiri-Yeboah, D., Traore, G., et al. (2016) Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso. BioMed Research International, 2016, Article ID: 7092583. https://doi.org/10.1155/2016/7092583
|
[11]
|
Tovo, S.F., Zohoncon, T.M., Dabiré, A.M., Ilboudo, R., Tiemtoré, R.Y., Obiri-Yeboah, D., et al. (2021) Molecular Epidemiology of Human Papillomaviruses, Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium among Female Sex Workers in Burkina Faso: Prevalence, Coinfections and Drug Resistance Genes. Tropical Medicine and Infectious Disease, 6, Article 90.
https://doi.org/10.3390/tropicalmed6020090
|
[12]
|
Ilboudo, R., Traoré, E., Zohoncon, T., Ouédraogo, R., Traore, I., Bado, P., et al. (2020) Prevalence and Characterization of High-Risk Human Papillomavirus. Genotypes among a Group of Sex Workers in Ouagadougou, Burkina Faso. EC Gynaecology, 9, 1-9.
|
[13]
|
Ouedraogo, T., Wendé, C., Djigma, F.W., Idani, B., Zohoncon, T.M., Sorgho, P.A., Bado, P., et al. (2020) Impact of Glutathione S-Transferase Genes Polymorphisms on Human Papillomavirus Infection and Pre-Cancerous Lesions in West African Women. International Journal of Genetics and Molecular Biology, 12, 59-70.
|
[14]
|
Kelly, H.A., Sawadogo, B., Chikandiwa, A., Segondy, M., Gilham, C., Lompo, O., et al. (2017) Epidemiology of High-Risk Human Papillomavirus and Cervical Lesions in African Women Living with HIV/AIDS: Effect of Anti-Retroviral Therapy. AIDS, 31, 273-285. https://doi.org/10.1097/QAD.0000000000001301
|
[15]
|
Ouédraogo, C., Zohoncon, T.M., Traoré, E.M.A., Ouattara, S., Bado, P., Ouedraogo, C.T., et al. (2016) Distribution of High-Risk Human Papillomavirus Genotypes in Precancerous Cervical Lesions in Ouagadougou, Burkina Faso. Open Journal of Obstetrics and Gynecology, 39, 196-204. https://doi.org/10.4236/ojog.2016.64025
|
[16]
|
Sanou-Lamien, A., Ki, R., Zohoncon-Kone, T., Ouedraogo, A., Konsegre, V., Ido, F., et al. (2018) Aspects socio-démographiques et histopathologiques des lésions pré-cancéreuses de haut grade et cancéreuses du col utérin et caractérisation moléculaire des HPV oncogènes impliqués à Ouagadougou (Burkina Faso). Revue Africaine de Pathologie, 17, 48-55.
|
[17]
|
Zohoncon, T.M., Bado, P., Ouermi, D., Traoré, E.M.A., Djigma, F.W., Traore, I.M.A., et al. (2016) Molecular Characterization of High-Risk Human Papillomavirus Genotypes Involved in Invasive Cervical Cancer From Formalin-Fixed, Formalin Paraffin-Embedded Tissues in Ouagadougou, Burkina Faso. International Journal of Current Research, 8, 39314-39318.
|
[18]
|
Kabre, K.M., Ouermi, D., Zohoncon, T.M., Traore, F.P.W., Gnoumou, O.P.D.P., Ouedraogo, R.A., et al. (2022) Molecular Epidemiology of Human Papillomavirus in Pregnant Women in Burkina Faso. Biomolecular Concepts, 13, 334-340.
https://doi.org/10.1515/bmc-2022-0026
|
[19]
|
Ouédraogo, C.M.R., Rahimy, R.M.L., Zohoncon, T.M., Djigma, F.W., Yonli, A.T., Ouermi, D., et al. (2015) épidémiologie et caractérisation des génotypes à haut risque de Papillomavirus humain dans une population d’adolescentes sexuellement actives à Ouagadougou. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 44, 715-722. https://doi.org/10.1016/j.jgyn.2014.12.021
|
[20]
|
Djigma, F.W., Ouédraogo, C., Karou, D.S., Sagna, T., Bisseye, C., Zeba, M., et al. (2011) Prevalence and Genotype Characterization of Human Papillomaviruses among HIV-Seropositive in Ouagadougou, Burkina Faso. Acta Tropica, 117, 202-206.
https://doi.org/10.1016/j.actatropica.2010.12.007
|
[21]
|
Djigma, F.W., Zohoncon, T.M., Douamba, Z., Sorgho, P.A., Obiri-Yeboah, D., Ouattara, A.K., et al. (2020) Molecular Genotyping of Human Papillomavirus among HIV-Infected and HIV-Uninfected Women in Ouagadougou, Burkina Faso. Journal of Medical Biomedical and Applied Sciences, 8, 324-333.
|
[22]
|
Sagna, T., Djigma, F., Zeba, M., Bisseye, C., Karou, S., Ouermi, D., et al. (2010) Human Papillomaviruses Prevalence and Genital Co-Infections in HIV-Seropositive Women in Ouagadougou (Burkina Faso). Pakistan Journal of Biological Sciences, 13, 951-955. https://doi.org/10.3923/pjbs.2010.951.955
|
[23]
|
Petrick, J.L. and McGlynn, K.A. (2019) The Changing Epidemiology of Primary Liver Cancer. Current Epidemiology Reports, 6, 104-111.
https://doi.org/10.1007/s40471-019-00188-3
|
[24]
|
Meda, N., Tuaillon, E., Kania, D., Tiendrebeogo, A., Pisoni, A., Zida, S., et al. (2018) Hepatitis B and C Virus Seroprevalence, Burkina Faso: A Cross-Sectional Study. Bulletin of the World Health Organization, 96, 750-759.
https://doi.org/10.2471/BLT.18.208603
|
[25]
|
Tao, I., Compaoré, T.R., Diarra, B., Djigma, F., Zohoncon, T.M., Assih, M., et al. (2014) Seroepidemiology of Hepatitis B and C Viruses in the General Population of Burkina Faso. Hepatitis Research and Treatment, 2014, Article ID: 781843.
https://doi.org/10.1155/2014/781843
|
[26]
|
Luo, C., Yu, S., Zhang, J., Wu, X., Dou, Z., Li, Z., et al. (2022) Hepatitis B or C Viral Infection and the Risk of Cervical Cancer. Infectious Agents and Cancer, 17, Article No. 54. https://doi.org/10.1186/s13027-022-00466-8
|
[27]
|
Yelemkoure, E.T., Yonli, A.T., Sombie, H.K., Tao, I., Zouré, A.A., Ouattara, A.K., et al. (2022) Seroprevalence, Genotyping, and Monitoring of Hepatitis C Viral Loads in Patients on Antivirals in Burkina Faso. Intervirology, 65, 151-159.
https://doi.org/10.1159/000519848
|
[28]
|
Bomfim-Hyppólito, S., Eleuterio, J., Nunes, G.C., Bomfim-Hyppólito, E., Franco, E.S. and Neto, R.D.J.P. (2013) HIV or Human Papillomavirus Co-Infection among Brazilian Individuals Infected with Hepatitis B and/or Hepatitis C. International Journal of Gynecology & Obstetrics, 122, 258-260.
https://doi.org/10.1016/j.ijgo.2013.04.012
|
[29]
|
Lacey, C.J. (2019) HPV Vaccination in HIV Infection. Papillomavirus Research, 8, Article 100174. https://doi.org/10.1016/j.pvr.2019.100174
|
[30]
|
Stanley, M.A. and Sterling, J.C. (2014) Host Responses to Infection with Human Papillomavirus. Current Problems in Dermatology, 45, 58-74.
https://doi.org/10.1159/000355964
|
[31]
|
Henri, E., Paul, E.J., Roger, E.M., Theophile, N.N., Valere, M.K., Merlin, B., et al. (2020) HIV+ Status and Cervical Cancer: Cytological Aspects of Cervical Smear in Cameroon Setting. Open Journal of Obstetrics and Gynecology, 10, 76-84.
https://doi.org/10.4236/ojog.2020.101007
|
[32]
|
Ouedraogo, R.A., Ouedraogo, R.A., Zohoncon, T.M., Zohoncon, T.M., Zohoncon, T.M., Traore, I.M.A., et al. (2020) Genotypic Distribution of Human Oncogenic Papillomaviruses in Sexually Active Women in Burkina Faso: Central, Central-Eastern and Hauts-Bassins Regions. Biomolecular Concepts, 11, 125-136.
https://doi.org/10.1515/bmc-2020-0011
|
[33]
|
Bosch, F.X., Lorincz, A., Meijer, C.J.L.M. and Shah, K.V. (2002) The Causal Relation between Human Papilloma-Virus and Cervical Cancer. Journal of Clinical Pathology, 55, 244-265. https://doi.org/10.1136/jcp.55.4.244
|
[34]
|
De Sanjose, S., Bosch, F.X., Mufioz, N., Tafur, L., Gili, M., Izarzugaza, I., et al. (1996) Socioeconomic Differences in Cervical Cancer: Two Case-Control Studies in Colombia and Spain. American Journal of Public Health, 86, 1532-1538.
https://doi.org/10.2105/AJPH.86.11.1532
|
[35]
|
Munoz, N., Franceschi, S., Bosetti, C., Moreno, V., Herrero, R., Smith, J.S., et al. (2002) Role of Parity and Human Papillomavirus in Cervical Cancer: The IARC Multicentric Case-Control Study. The Lancet, 359, 1093-1101.
https://doi.org/10.1016/S0140-6736(02)08151-5
|
[36]
|
Levi, J.E., Longatto-Filho, A., Eluf-Neto, J., Rodrigues, C.L., Oliveira, C.M., Carloni, A.C., et al. (2014) Evaluation of HPV Molecular Tests in Primary Screening for Cervical Cancer in Brazil. Open Journal of Obstetrics and Gynecology, 4, 470-478.
https://doi.org/10.4236/ojog.2014.48068
|
[37]
|
Fabiano, V., Mariani, L., Giovagnoli, M.R., Raffa, S., Vincenzoni, C., de Michetti, F., et al. (2010) Cervical Cancer Screening Program Based on HPV Testing and Conventional Papanicolaou Cytology for Jail Inmates. Health, 2, 1027-1032.
https://doi.org/10.4236/health.2010.29151
|
[38]
|
Osnytska, Y., Martin, L.R. and Goodman, A. (2023) Cervical Cancer Prevention Challenges and Barriers to Cervical Cancer Screening and HPV Vaccinations in Ukraine and Eastern Europe. Health, 15, 525-543.
https://doi.org/10.4236/health.2023.156036
|
[39]
|
Oyervides-Munoz, M.A., Pérez-Maya, A.A., Sánchez-Domínguez, C.N., Berlanga-Garza, A., Antonio-Macedo, M., Valdéz-Chapa, L.D., et al. (2020) Multiple HPV Infections and Viral Load Association in Persistent Cervical Lesions in Mexican Women. Viruses, 12, Article 380. https://doi.org/10.3390/v12040380
|
[40]
|
Bado, P., Djigma, F.W., Zohoncon, T.M., Obiri-Yeboah, D., Traoré, E.M.A., Ouattara, A.K., et al. (2020) Erratum: Polymorphism of MMP1 and MMP3 Promoter Regions and HR-HPV Infection in Women from Burkina Faso and Cote d’Ivoire. BioMolecular Concepts, 11, 142. https://doi.org/10.1515/bmc-2020-0013
|
[41]
|
Traore, M.A.E., Djigma, W.F., Setor, M.A., Zohoncon, T.M., Obiri-Yeboah, D., Ouattara, A.K., et al. (2019) Mspi Polymorphisms (rs4646903) of the CYP1A1 Gene in Women Infected with Human Papillomavirus in West Africa. International Journal of Current Research, 11, 8390-8396.
|